These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 31344486)

  • 1. Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease.
    Sun N; Mormino EC; Chen J; Sabuncu MR; Yeo BTT;
    Neuroimage; 2019 Nov; 201():116043. PubMed ID: 31344486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.
    Zhang X; Mormino EC; Sun N; Sperling RA; Sabuncu MR; Yeo BT;
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6535-E6544. PubMed ID: 27702899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.
    Baumeister H; Vogel JW; Insel PS; Kleineidam L; Wolfsgruber S; Stark M; Gellersen HM; Yakupov R; Schmid MC; Lüsebrink F; Brosseron F; Ziegler G; Freiesleben SD; Preis L; Schneider LS; Spruth EJ; Altenstein S; Lohse A; Fliessbach K; Vogt IR; Bartels C; Schott BH; Rostamzadeh A; Glanz W; Incesoy EI; Butryn M; Janowitz D; Rauchmann BS; Kilimann I; Goerss D; Munk MH; Hetzer S; Dechent P; Ewers M; Scheffler K; Wuestefeld A; Strandberg O; van Westen D; Mattsson-Carlgren N; Janelidze S; Stomrud E; Palmqvist S; Spottke A; Laske C; Teipel S; Perneczky R; Buerger K; Schneider A; Priller J; Peters O; Ramirez A; Wiltfang J; Heneka MT; Wagner M; Düzel E; Jessen F; Hansson O; Berron D
    Brain; 2024 Jul; 147(7):2400-2413. PubMed ID: 38654513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease.
    Phillips JS; Das SR; McMillan CT; Irwin DJ; Roll EE; Da Re F; Nasrallah IM; Wolk DA; Grossman M
    Hum Brain Mapp; 2018 Feb; 39(2):691-708. PubMed ID: 29105977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
    Ten Kate M; Dicks E; Visser PJ; van der Flier WM; Teunissen CE; Barkhof F; Scheltens P; Tijms BM;
    Brain; 2018 Dec; 141(12):3443-3456. PubMed ID: 30351346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities.
    de Flores R; Das SR; Xie L; Wisse LEM; Lyu X; Shah P; Yushkevich PA; Wolk DA
    J Neurosci; 2022 Mar; 42(10):2131-2141. PubMed ID: 35086906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
    Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O
    Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.
    Nho K; Risacher SL; Crane PK; DeCarli C; Glymour MM; Habeck C; Kim S; Lee GJ; Mormino E; Mukherjee S; Shen L; West JD; Saykin AJ;
    Brain Imaging Behav; 2012 Dec; 6(4):551-67. PubMed ID: 23070747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-pathological contributions toward atrophy patterns in the Alzheimer's disease continuum.
    Mohanty R; Ferreira D; Westman E
    Front Neurosci; 2024; 18():1355695. PubMed ID: 38655107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis.
    Scheltens NM; Galindo-Garre F; Pijnenburg YA; van der Vlies AE; Smits LL; Koene T; Teunissen CE; Barkhof F; Wattjes MP; Scheltens P; van der Flier WM
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):235-43. PubMed ID: 25783437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal tau asymmetry spectrum influences divergent behavior and language patterns in Alzheimer's disease.
    Younes K; Smith V; Johns E; Carlson ML; Winer J; He Z; Henderson VW; Greicius MD; Young CB; Mormino EC;
    Brain Behav Immun; 2024 Jul; 119():807-817. PubMed ID: 38710339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.
    Davatzikos C; Xu F; An Y; Fan Y; Resnick SM
    Brain; 2009 Aug; 132(Pt 8):2026-35. PubMed ID: 19416949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.
    Cho H; Choi JY; Lee HS; Lee JH; Ryu YH; Lee MS; Jack CR; Lyoo CH
    J Nucl Med; 2019 Nov; 60(11):1611-1621. PubMed ID: 30926651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau and atrophy: domain-specific relationships with cognition.
    Digma LA; Madsen JR; Reas ET; Dale AM; Brewer JB; Banks SJ;
    Alzheimers Res Ther; 2019 Jul; 11(1):65. PubMed ID: 31351484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological heterogeneity in ADNI amnestic mild cognitive impairment.
    Nettiksimmons J; DeCarli C; Landau S; Beckett L;
    Alzheimers Dement; 2014 Sep; 10(5):511-521.e1. PubMed ID: 24418061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.